Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01288703 · ClinicalTrials.gov registry record
Computerized-Adaptive Testing: Feasibility In Women With Pelvic Floor Disorders (CAT)
A clinical trial of Urinary Incontinence, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT01288703 is a study of Urinary Incontinence that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 20 participants, below the 262-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01288703, a study of Urinary Incontinence, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this pilot-study is to evaluate the feasibility and acceptability of PROMIS computerized-adaptive testing in women with urinary incontinence.
Conditions Studied
Study Locations (1)
Rhode Island
- Women & Infants Hospital Division of Urogynecology - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01288703
The ClinicalTrials.gov registry entry for NCT01288703 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (92% lower). The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 0 interventions.
NCT01288703 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01288703 about?
NCT01288703 is a clinical study titled "Computerized-Adaptive Testing: Feasibility In Women With Pelvic Floor Disorders (CAT)". The objective of this pilot-study is to evaluate the feasibility and acceptability of PROMIS computerized-adaptive testing in women with urinary incontinence.
What is the current status of trial NCT01288703?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2012-02.
What conditions does trial NCT01288703 study?
This clinical trial studies the following conditions: Urinary Incontinence.
Who is sponsoring clinical trial NCT01288703?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01288703 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.